Hepatocellular cancer, the most common primary liver malignancy, is the fourth-leading cause of cancer-related deaths globally.
Amit Mahipal, MBBS
Advertisement
Articles by Amit Mahipal, MBBS
Amit Mahipal, MBBS, senior associate consultant, Division of Medical Oncology, Department of Oncology, associate professor of oncology, Mayo Clinic, discusses emerging molecular markers in patients with metastatic colorectal cancer (mCRC).
Amit Mahipal, MBBS, senior associate consultant, Division of Medical Oncology, Department of Oncology, associate professor of oncology, Mayo Clinic, discusses maintenance therapy in colorectal cancer (CRC).
Amit Mahipal, MBBS, professor of medicine, Mayo Clinic, discusses the treatment of patients with newly diagnosed metastatic colorectal cancer.
Advertisement
Latest Updated Articles
Pivotal Trial Results Look to Shake Up HCC TreatmentPublished: October 18th 2021 | Updated:
Dr. Mahipal on Treatment of Newly Diagnosed mCRCPublished: March 22nd 2019 | Updated:
Dr. Mahipal on Maintenance Therapy in CRCPublished: April 16th 2019 | Updated:
Dr. Mahipal on Molecular Markers in mCRCPublished: May 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
2
Unpacking the FDA Approvals That Reshaped Cancer Care in 2025
3
FDA Grants Orphan Drug Designation to Gotistobart in Squamous NSCLC
4
Nogapendekin Alfa Inbakicept Plus NK Cell Therapy Yields Strong OS Signal in Recurrent Glioblastoma
5